Pneumococcal capsular serotypes and lung infection

Thorax

Volumn 67, Issue 6, 2012, Pages 473-474

  Brown, Jeremy Stuart ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; CAPSULAR SEROTYPE; COMMUNITY ACQUIRED PNEUMONIA; EDITORIAL; EMPYEMA; HUMAN; IMMUNOASSAY; IMMUNOGENICITY; LUNG INFECTION; MENINGITIS; MUCOSAL IMMUNITY; NONHUMAN; PNEUMOCOCCAL INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

FEMALE; HUMANS; INPATIENTS; MALE; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 84862787571     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201739     Document Type: Editorial

References (13)

1. Brown JS. Geography and the aetiology of community acquired pneumonia. Respirology 2009;14:1068-71.
2. Hyams C, Camberlein E, Cohen JM, et al. The Streptococcus pneumoniae capsule inhibits complement activity neutrophil phagocytosis by multiple mechanisms. Infect Immun 2010;78:704-15.
3. Bewick T, Sheppard C, Greenwood S, et al. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax 2012;67:540-5.
4. Hyams C, Yuste J, Bax K, et al. Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on capsular serotype. Infect Immun 2010;78:716-25.
5. Weinberger DM, Trzciński K, Lu YJ, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 2009;5:e1000476.
6. Sanchez CJ, Hinojosa CA, Shivshankar P, et al. Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence. PLoS One 2011;6:e26587.
7. Sleeman KL, Griffiths D, Shackley F, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population children. J Infect Dis 2006;194:682-8. (Pubitemid 44297855)
8. Weinberger DM, Harboe ZB, Sanders EA, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010;51:692-9.
9. Strachan RE, Cornelius A, Gilbert GL, et al. Bacterial causes of empyema in children, Australia, 2007-2009. Emerg Infect Dis 2011;17:1839-45.
10. Domenech A, Ardanuy C, Calatayud L, et al. Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease. J Antimicrob Chemother 2011;66:487-93.
11. Moberley SA, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422.
12. Dinleyici EC, Yargic ZA. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era. Expert Rev Vaccines 2008;7:1367-94.
13. Miller E, Andrews NJ, Waight PA, et al. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011;11:760-8.